Drugs / TFC-003-R1
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07662759 Comparator | Dec 2025 → Mar 2027 expected | ocular hypertension, open-angle glaucoma | Kukje Pharma | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TFC-003-R1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07662759 ↗ |
| Route | Topical | “TFC-003-R1 will be administered as one drop into the affected eye(s)” NCT07662759 ↗ |